tiprankstipranks
Assembly Biosciences (ASMB)
NASDAQ:ASMB
US Market
ASMB
Assembly Biosciences
RESEARCH TOOLSreports

Assembly Biosciences (ASMB) Stock News & Sentiment

581 Followers
Assembly Biosciences Adopts 2026 Performance-Based Bonus Plan
Premium
Company Announcements
Assembly Biosciences Adopts 2026 Performance-Based Bonus Plan
9d ago
8K
ASMB
Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial
Premium
Company Announcements
Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial
17d ago
ASMB
Is ASMB a Buy, Before Earnings?
Premium
Pre-Earnings
Is ASMB a Buy, Before Earnings?
1M ago
ASMB
Gilead Partnership and Positive HSV Data De‑Risk Assembly Biosciences, Supporting Buy Rating and $50 Price Target
Premium
Ratings
Gilead Partnership and Positive HSV Data De‑Risk Assembly Biosciences, Supporting Buy Rating and $50 Price Target
4M ago
ASMB
Assembly Biosciences Completes Key Phase 1a Study on ABI-6250
Premium
Company Announcements
Assembly Biosciences Completes Key Phase 1a Study on ABI-6250
4M ago
ASMB
Positive Buy Rating for Assembly Biosciences Driven by Promising HSV-2 Program and Strategic Partnerships
Premium
Ratings
Positive Buy Rating for Assembly Biosciences Driven by Promising HSV-2 Program and Strategic Partnerships
4M ago
ASMB
Assembly Biosciences Reports Positive Phase 1b Results
Premium
Company Announcements
Assembly Biosciences Reports Positive Phase 1b Results
4M ago
8K
ASMB
More ASMB News >

ASMB News on the Web

Assembly Biosciences (ASMB) Gets a Buy from Guggenheim
TipRanks News
Neutral
Assembly Biosciences price target raised to $43 from $39 at Guggenheim
TipRanks News
Bullish
Assembly Biosciences Adopts 2026 Performance-Based Bonus Plan
TipRanks News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Neutral
Analysts’ Top Healthcare Picks: COMPASS Pathways (CMPS), Assembly Biosciences (ASMB)
TipRanks News
Neutral
Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial
TipRanks News
Bullish
Assembly Biosciences Reports Strong Cash Growth and Gilead Collaboration Milestone as Pipeline Advances
Market Chameleon
Neutral
Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates
Zacks
Bullish

News Score - Last 7 Days

Neutral
ASMB
Sector Average
Media Buzz
This Week2 articles
Weekly Average2.25 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ASMB’s Media Buzz Sentiment?
2 articles about ASMB were published this week. In an average week, 2.25 articles are published.
    What is ASMB’s weekly average amount of articles?
    In an average week, 2.25 articles about ASMB are published.
      What is ASMB’s News Sentiment?
      100% of articles about ASMB were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        AORTArtivion
        HUMHumana
        ORGOOrganogenesis Holdings
        UNHUnitedHealth Group Incorporated Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S
        Showing the stocks with the most bullish news sentiment over the past week